Beneficient (BENF) Cash & Equivalents (2022 - 2025)

Beneficient has disclosed Cash & Equivalents across 4 years of filings, most recently posting $7.9 million for Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $7.9 million, up 89.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.9 million (up 89.61% YoY), and the FY2025 annual result was $1.3 million, down 82.99% from the prior year.
• Cash & Equivalents came in at $7.9 million for Q4 2025 at Beneficient, up from $4.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $70.6 million in Q1 2022 to a low of $1.3 million in Q1 2025.
• The 4-year median for Cash & Equivalents is $4.9 million (2025), against an average of $10.7 million.
• Across the five-year window, Cash & Equivalents sank 87.64% in 2023 and jumped 89.61% in 2025, its largest moves.
• Beneficient's Cash & Equivalents stood at $70.6 million in 2022, then slumped by 84.13% to $11.2 million in 2023, then tumbled by 62.96% to $4.1 million in 2024, then surged by 89.61% to $7.9 million in 2025.
• The last three Cash & Equivalents figures came in at $7.9 million (Q4 2025), $4.9 million (Q3 2025), and $7.6 million (Q2 2025), per Business Quant data.